JP2007516296A5 - - Google Patents

Download PDF

Info

Publication number
JP2007516296A5
JP2007516296A5 JP2006547427A JP2006547427A JP2007516296A5 JP 2007516296 A5 JP2007516296 A5 JP 2007516296A5 JP 2006547427 A JP2006547427 A JP 2006547427A JP 2006547427 A JP2006547427 A JP 2006547427A JP 2007516296 A5 JP2007516296 A5 JP 2007516296A5
Authority
JP
Japan
Prior art keywords
compound according
medicament
manufacture
compound
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006547427A
Other languages
English (en)
Japanese (ja)
Other versions
JP4791975B2 (ja
JP2007516296A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/043492 external-priority patent/WO2005063765A1/en
Publication of JP2007516296A publication Critical patent/JP2007516296A/ja
Publication of JP2007516296A5 publication Critical patent/JP2007516296A5/ja
Application granted granted Critical
Publication of JP4791975B2 publication Critical patent/JP4791975B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006547427A 2003-12-23 2004-12-21 サイクリン依存性キナーゼの阻害剤、組成物およびそれに関連する使用 Expired - Fee Related JP4791975B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US53187203P 2003-12-23 2003-12-23
US60/531,872 2003-12-23
US56013804P 2004-04-06 2004-04-06
US60/560,138 2004-04-06
US61648004P 2004-10-06 2004-10-06
US60/616,480 2004-10-06
PCT/US2004/043492 WO2005063765A1 (en) 2003-12-23 2004-12-21 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto

Publications (3)

Publication Number Publication Date
JP2007516296A JP2007516296A (ja) 2007-06-21
JP2007516296A5 true JP2007516296A5 (enExample) 2009-08-27
JP4791975B2 JP4791975B2 (ja) 2011-10-12

Family

ID=34743691

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006547427A Expired - Fee Related JP4791975B2 (ja) 2003-12-23 2004-12-21 サイクリン依存性キナーゼの阻害剤、組成物およびそれに関連する使用

Country Status (12)

Country Link
US (1) US8097619B2 (enExample)
EP (1) EP1709051A1 (enExample)
JP (1) JP4791975B2 (enExample)
KR (1) KR101155883B1 (enExample)
AU (1) AU2004309415B2 (enExample)
BR (1) BRPI0418095A (enExample)
CA (1) CA2551640C (enExample)
EA (1) EA013117B1 (enExample)
IL (1) IL176543A0 (enExample)
MX (1) MXPA06007399A (enExample)
NO (1) NO20063186L (enExample)
WO (1) WO2005063765A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2298292A3 (en) * 2004-06-18 2011-08-10 Agennix USA Inc. Kinase inhibitors for treating cancers
EP2019101A1 (en) 2007-07-26 2009-01-28 GPC Biotech AG Pyrazol[3,4-d]pyrimidin-4-one useful as Kinase Inhibitor
JP2013525370A (ja) 2010-04-22 2013-06-20 ヤンセン ファーマシューティカ エヌ.ベー. ケトヘキソキナーゼ阻害剤として有用なインダゾール化合物
BRPI1107312B1 (pt) 2011-11-25 2021-09-08 Universidade Federal De Santa Catarina Composto de acil-hidrazona
JP7166252B2 (ja) 2016-11-30 2022-11-07 メディツィーニシェ・ウニヴェルジテート・インスブルック サイクリン依存性キナーゼ阻害剤としての3-アミノ-1,5-ジヒドロピラゾロ[3,4-d]ピリミジン-4-オン

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3211732A (en) 1965-10-12 Pyrazolob:x-d]pyrlil/hdines
CH398626A (de) 1960-05-11 1966-03-15 Ciba Geigy Verfahren zur Herstellung neuer Pyrazolopyrimidine
JPS60130521A (ja) 1983-12-19 1985-07-12 Morishita Seiyaku Kk 抗癌剤
US4678499A (en) 1985-03-11 1987-07-07 E. I. Du Pont De Nemours And Company Herbicidal sulfonamides
JPS6299361A (ja) 1985-10-25 1987-05-08 Morishita Seiyaku Kk インデノ〔1,2−c〕ピラゾ−ル誘導体
TW370529B (en) 1992-12-17 1999-09-21 Pfizer Pyrazolopyrimidines
US5593997A (en) 1995-05-23 1997-01-14 Pfizer Inc. 4-aminopyrazolo(3-,4-D)pyrimidine and 4-aminopyrazolo-(3,4-D)pyridine tyrosine kinase inhibitors
US5866702A (en) 1996-08-02 1999-02-02 Cv Therapeutics, Incorporation Purine inhibitors of cyclin dependent kinase 2
EP1071668B1 (en) 1998-04-21 2009-06-03 Bristol-Myers Squibb Pharma Company 5-aminoindeno[1,2-c]pyrazol-4-ones as anti-cancer and anti-proliferative agents
US6407103B2 (en) * 1998-04-21 2002-06-18 Bristol-Myers Squibb Pharma Company Indeno [1,2-c] pyrazol-4-ones and their uses
US6559152B2 (en) 1998-10-13 2003-05-06 Dupont Pharmaceuticals Company 6-substituted pyrazolo[3,4-d]pyrimidin-4-ones useful as cyclin dependent kinase inhibitors
US6531477B1 (en) 1998-10-13 2003-03-11 Dupont Pharmaceuticals Company 6-substituted pyrazolo [3,4-d] pyrimidin-4-ones useful as cyclin dependent kinase inhibitors
US6291504B1 (en) 1999-10-20 2001-09-18 Dupont Pharmaceuticals Company Acylsemicarbazides and their uses
EP1414804A1 (en) 2000-10-20 2004-05-06 Bristol-Myers Squibb Pharma Company Acylsemicarbazides and their use as cyclin dependent kinase (cdk) inhibitors
US6491971B2 (en) 2000-11-15 2002-12-10 G.T. Equipment Technologies, Inc Release coating system for crucibles
US6706718B2 (en) 2000-12-01 2004-03-16 Bristol-Myers Squibb Company 3-(2,4-dimethylthiazol-5-yl)indeno[1,2-c]pyrazol-4-one derivatives and their uses
US7605175B2 (en) * 2001-03-02 2009-10-20 Gpc Biotech Ag Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
JP4343534B2 (ja) 2001-03-02 2009-10-14 ゲーペーツェー バイオテック アクチェンゲゼルシャフト 3ハイブリッド・アッセイ・システム
WO2003004491A1 (en) 2001-07-06 2003-01-16 Bristol-Myers Squibb Pharma Company Semicarbazides and their uses
US20040248905A1 (en) 2001-07-10 2004-12-09 Markwalder Jay A 6-Substituted pyrazolo [3,4-d] pyrimidin-4-ones useful as cyclin dependent kinase inhibitors
PL369742A1 (en) * 2001-10-15 2005-05-02 Gpc Biotech Inc. Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
US6753329B2 (en) 2001-12-03 2004-06-22 Gpc Biotech Inc. Inhibitors of cyclin-dependent kinases, compositions and uses related thereto

Similar Documents

Publication Publication Date Title
JP2009535352A5 (enExample)
JP2021063088A5 (enExample)
JP2013518107A5 (enExample)
JP2009502743A5 (enExample)
JP2011528713A5 (enExample)
JP2006523216A5 (enExample)
JP2013507439A5 (enExample)
JP2017531038A5 (enExample)
JP2016508134A5 (enExample)
JP2010514829A5 (enExample)
JP2020512337A5 (enExample)
JP2020507589A5 (enExample)
MX2012007410A (es) Compuestos antivirales novedosos.
JP2007145875A5 (enExample)
JP2006182786A5 (enExample)
CN113993860A (zh) 作为kras g12c突变蛋白抑制剂的七元杂环类衍生物
JP2014518266A5 (enExample)
JP2013519645A5 (enExample)
JP2005508955A5 (enExample)
JP2008539267A5 (enExample)
EP2039686A4 (en) DIHYDROPYRIMIDIN COMPOUNDS AND THEIR USES IN THE MANUFACTURE OF MEDICAMENTS FOR THE TREATMENT AND PREVENTION OF ANTIVIRAL DISEASES
CN115315423A (zh) 取代芳基类化合物
CA2671470A1 (en) Powder formulation for valganciclovir
RU2013148779A (ru) Лечение инфекции вируса гепатита в по отдельности или в комбинации с вирусом гепатита дельта и родственных заболеваний печени
JP2008513510A5 (enExample)